0001213900-24-059878.txt : 20240708
0001213900-24-059878.hdr.sgml : 20240708
20240708174627
ACCESSION NUMBER: 0001213900-24-059878
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240703
FILED AS OF DATE: 20240708
DATE AS OF CHANGE: 20240708
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Weisman Harlan F
CENTRAL INDEX KEY: 0001555563
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39102
FILM NUMBER: 241105932
MAIL ADDRESS:
STREET 1: C/O CORONADO BIOSCIENCES, INC.
STREET 2: 15 NEW ENGLAND EXECUTIVE PARK
CITY: BURLINGTON
STATE: MA
ZIP: 01803
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TFF Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001733413
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 824344737
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2600 VIA FORTUNA, SUITE 360
CITY: AUSTIN
STATE: TX
ZIP: 78746
BUSINESS PHONE: 737-802-1973
MAIL ADDRESS:
STREET 1: 2600 VIA FORTUNA, SUITE 360
CITY: AUSTIN
STATE: TX
ZIP: 78746
4
1
ownership.xml
X0508
4
2024-07-03
0
0001733413
TFF Pharmaceuticals, Inc.
TFFP
0001555563
Weisman Harlan F
1751 RIVER RUN, SUITE 400
FORT WORTH
TX
76107
1
1
0
0
President and CEO
0
Common Stock
2024-07-03
4
A
0
27480
0
A
842095
D
Stock Options (Right to Buy)
1.82
2024-07-03
4
A
0
27480
0
A
2025-06-19
2034-07-03
Common Stock
27480
27480
D
Represents shares of common stock underlying restricted stock units ("RSUs"). Each RSU entitles its holder to receive one share of common stock of the issuer. The RSUs vest and settle in sixteen equal quarterly installments with a one-year cliff.
One-quarter of the options vest and first become exercisable on June 19, 2025 and the remainder of the options vest and first become exercisable in 12 equal quarterly installments commencing on September 19, 2025.
/s/ Harlan F. Weisman, by Kirk Allen Coleman, as Attorney-in-Fact
2024-07-05